TOMSK, RUSSIA / RankWire.AI / – Russian scientists have developed and tested a bioactive coating aimed at enhancing the interaction between titanium orthopedic implants and bone tissue. This material incorporates calcium phosphate sourced from hydroxyapatite and features nitrogen compounds linked to nitric oxide production. In laboratory experiments, human mesenchymal stem cells exhibited significantly improved survival rates on coated surfaces compared to uncoated titanium. The study analyzed the coating’s structural, chemical, mechanical, and biological responses, with peer-reviewed results published in Applied Surface Science in 2026.
The experimental coatings were produced by Tomsk Polytechnic University through reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. The researchers adjusted the nitrogen and argon gas ratios during deposition to observe how each mixture affected the resulting surface. The study tested five different conditions, from pure nitrogen to pure argon, assessing coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, laboratory tests evaluated the biological responses of living human cells to the modified titanium surfaces.
Results indicated that the argon content influenced various physical attributes of the coatings. Surfaces created with pure argon were denser and harder than those formed in pure nitrogen. The thickness of the coatings increased with higher argon proportions. Chemical analysis revealed nitrogen-carbon and nitrogen-oxygen bonds on the modified surfaces. The team then compared the growth of human mesenchymal stem cells on coated titanium versus uncoated titanium. The biological assessments focused on cell viability and markers indicative of bone cell development.
Enhanced cell viability observed in coating tests
According to the findings, cells exhibited notably higher survival rates on coated surfaces than on bare titanium. After seven days, coatings with elevated nitrogen levels also suppressed activity in certain genes associated with early stages of bone-cell differentiation. Despite this, the cells retained their ability to form bone tissue. The experiments were conducted under controlled laboratory conditions using human mesenchymal stem cells. It is important to note that the study did not involve testing the coating in clinical settings or on actual implanted devices in patients.
The biomedical evaluation was carried out by Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional contributions from specialists at Saint Petersburg State University. This research received backing through Russia’s state science program. The primary focus was to identify gas mixtures capable of producing optimal combinations of physical, chemical, and biological properties in the coatings. Hydroxyapatite’s calcium phosphate composition already makes it suitable for implant coatings, as it closely resembles the mineral component found in human bone.
Current research remains within laboratory testing phase
The research team has outlined plans for further testing beyond the initial seven-day cell assessments. They aim to analyze stem cell behavior over periods ranging from 10 to 28 days, as well as study the rate of coating dissolution and nitric oxide release into surrounding tissue in vivo. These investigations were not part of the current published laboratory results. Presently, the focus is on coated titanium substrates, their physical and chemical characteristics, and cellular responses in vitro, rather than on clinical outcomes related to orthopedic implants in patients.
The results offer detailed laboratory data on how varying ratios of nitrogen and argon influence calcium phosphate coatings on titanium surfaces. The study documented differences in thickness, density, hardness, chemical bonding, and cellular response among the different gas mixtures. The findings also confirmed that coated samples supported higher stem-cell survival compared to uncoated titanium under the experimental conditions. However, as this research remains at the preclinical stage, these experiments do not determine safety or effectiveness in human patients. Additional biological testing will be needed to evaluate properties not addressed in this initial study.